These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5304203)

  • 1. [1st observations on the pre- or post-operative application of 5-fluoruracil-tetracycline in the therapy of malignant neoplasms of the digestive system. Preliminary note].
    Gordon B; D'Alessandro R; Sheimberg MA
    Hospital (Rio J); 1967 Jun; 71(6):1661-8. PubMed ID: 5304203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of 5-fluorouracil (5FU) treatment of malignant neoplasms].
    Singer Z; Kuśnierczykówna J; Iwanicka B
    Pol Tyg Lek; 1974 Jun; 29(24):1033-7. PubMed ID: 4845080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of continuous intravenous 5-fluorouracil therapy in 27 patients with neoplasms of the digestive tract].
    Pilone A; Delprete S; Pierangeli S; Frosini G; Pezzoli M
    G Ital Chemioter; 1984; 31(3):249-52. PubMed ID: 6085574
    [No Abstract]   [Full Text] [Related]  

  • 4. [5-Fluorouracil(5-FU) in the treatment of adenocarcinomas of the digestive tract (apropos of 13 cases)].
    Vinhafs JC; Ferreira AJ
    Hospital (Rio J); 1967 Feb; 71(2):453-74. PubMed ID: 5302398
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of advanced digestive cancer with chemotherapy (author's transl)].
    Arraztoa J; Garcia C; Burmester M
    Rev Med Chil; 1974 Sep; 102(9):686-9. PubMed ID: 4456518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of treatment with 5-fluorouracil in 75 cases with neoplasms of the digestive tract].
    Paolucci R
    Policlinico Chir; 1971; 78(6):303-18. PubMed ID: 5146512
    [No Abstract]   [Full Text] [Related]  

  • 7. [The possibility of treating malignant tumors of the gastrointestinal tract with 5-fluoracil].
    Kosarev VA; Nikiforov AM
    Klin Med (Mosk); 1969 Feb; 47(2):115-9. PubMed ID: 5379248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of the clinical use of 5-fluorouracil in malignant tumor patients].
    Hara Y; Tobita Y; Kimura G; Fujimiya M; Watabe Y
    Gan No Rinsho; 1968 Jun; 14(6):481-5. PubMed ID: 5748506
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in clinical use of 5-fluorouracil].
    Evseenko LS; Disvetova VV; Korman DB; Levitin EI; Leenson BP; Orlova RS; Shiiataia OK
    Vopr Onkol; 1965; 11(11):69-75. PubMed ID: 5872983
    [No Abstract]   [Full Text] [Related]  

  • 10. [5-fluorouracil and its carcinostatic effects].
    Ishiyama S; Sakabe T; Ushio S; Yamagata S; Funabashi W
    Gan No Rinsho; 1967 Mar; 13(3):139-50. PubMed ID: 6070070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluorouracil, mitomycin-C and adriamycin in the treatment of metastasizing gastrointestinal adenocarcinomas].
    Späti B; Jungi WF; Mayr AC; Hammer B; Senn HJ
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1076-8. PubMed ID: 7423154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pre- and post-operative treatment of vasculopathic and aged patients: our experience with xanthinol nicotinate (Complamin)].
    Grugni P; Bolognesi L; Romitti M
    Acta Anaesthesiol; 1970; 21(2):217-23. PubMed ID: 5536299
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of pre- and post-operative irradiation for esophageal carcinoma].
    Iizuka T
    Rinsho Kyobu Geka; 1988 Dec; 8(6):567-71. PubMed ID: 9301884
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oncological treatment of gastrointestinal carcinoma].
    Cohen Y; Sorek M; Robinson E
    Harefuah; 1970 Sep; 79(6):252-4. PubMed ID: 4997781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 5-fluorouracil on digestive tract cancer. Study and results of 18 cases].
    Daccak M
    Rev Med Moyen Orient; 1967; 24(2):155-9. PubMed ID: 5248419
    [No Abstract]   [Full Text] [Related]  

  • 16. [A clinical investigation of the combination therapy of 1-(2-tetrahydrofuryl)-5-fluorouracil (FH) fine granules and 5-FU dry syrup].
    Nakazawa I; Goto Y; Ouchi E; Nomura N; Suzuki N; Kikuchi T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):722-5. PubMed ID: 6820906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regional cytostatic infusion therapy in patients with inoperable gastrointestinal carcinomas and metastases in the liver (author's transl)].
    Denck H
    Wien Med Wochenschr; 1980 Jan; 130(2):36-9. PubMed ID: 7385888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience.
    Ross PJ; Webb A; Cunningham D; Prendiville J; Norman AR; Oates J
    J Infus Chemother; 1996; 6(3):141-4. PubMed ID: 9229326
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice.
    Schwarz RE
    World J Surg Oncol; 2007 Mar; 5():32. PubMed ID: 17355626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic 5-fluorouracil for palliation of gastrointestinal cancer.
    Hart GD; Maxwell SB; Soots ML
    Appl Ther; 1968 Oct; 10(10):670-2. PubMed ID: 4177674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.